Fort Lee, NJ, United States of America

David Zammit

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Zammit: Innovator in Pharmaceutical Formulations

Introduction

David Zammit is a notable inventor based in Fort Lee, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of atopic dermatitis. His innovative work has led to the development of formulations that enhance the stability of active pharmaceutical ingredients.

Latest Patents

David Zammit holds 1 patent for his invention titled "Formulations, methods, kits, and dosage forms for treating atopic dermatitis and for improved stability of an active pharmaceutical ingredient." This patent encompasses various embodiments related to formulations and methods for treating inflammatory disorders, including atopic dermatitis and cancer. The formulation includes granules that consist of a micronized active ingredient, granulation binders, fillers, disintegrants, and antioxidants. The methods of treatment involve orally administering the active ingredient in amounts ranging from about 20 mg to about 80 mg.

Career Highlights

David Zammit is associated with Libertas Bio, Inc., where he continues to advance his research and development efforts. His work is pivotal in creating effective treatments for patients suffering from inflammatory conditions.

Collaborations

David collaborates with talented professionals in his field, including Aruna Railkar and Paras Jariwala. Their combined expertise contributes to the innovative projects at Libertas Bio, Inc.

Conclusion

David Zammit's contributions to pharmaceutical formulations demonstrate his commitment to improving treatment options for patients with atopic dermatitis. His innovative approach and collaboration with skilled colleagues position him as a key figure in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…